Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...

Age-related macular degeneration (AMD) is a major cause of blindness, especially in older adults. A key feature of early AMD ...

Older adults with diabetes who are using semaglutide are twice as likely to develop neovascular age-related macular ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Bobbi Conner talks with MUSC's Dr. Mauricio Pereira about the diagnosis and treatment of macular degeneration.

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...

Ocular Therapeutix showcases innovative retinal disease treatments at the Clinical Trials Summit 2025 in Las Vegas, featuring ...

The findings in animals may help advance treatment options for dry age-related macular degeneration (AMD), which ... the light-sensitive retina tissue at the back of the eye degenerates.

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...